Maxdulin 50/20 Capsule DR is a combination medication containing Pregabalin 50mg and Duloxetine 20mg, formulated for the management of neuropathic pain and generalized anxiety disorders. Pregabalin, an anticonvulsant, modulates calcium channels to reduce neurotransmitter release, thereby alleviating nerve pain and seizures. Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), enhances mood and pain control by increasing the levels of serotonin and norepinephrine in the central nervous system. The delayed-release (DR) formulation ensures optimal absorption and sustained therapeutic effect. Maxdulin 50/20 is indicated for conditions such as diabetic peripheral neuropathy, fibromyalgia, post-herpetic neuralgia, and major depressive disorder with comorbid anxiety. It is essential to administer the capsule as prescribed, typically once or twice daily, with or without food. Patients should be monitored for potential side effects including dizziness, somnolence, dry mouth, nausea, and possible mood changes. Caution is advised in patients with hepatic or renal impairment, and gradual dose adjustments are recommended to minimize withdrawal symptoms upon discontinuation. Maxdulin 50/20 Capsule DR should be used under strict medical supervision to ensure safety and efficacy in managing neuropathic pain and associated psychiatric conditions.